Spectral Medical Inc.

EDT.TOTSXHealthcare● Active

$1.39

+$0.01(+0.72%)

Market Cap$407852397

P/E Ratio—

52W High$1.84

52W Low$0.77

Avg Volume56K

Open$1.38

Beta0.23

Free Cash Flow Financials Revenue

Spectral Medical Inc. (EDT.TO) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

EDT.TO · free cash flow · updated Jun 9, 2026

Core FCF metrics

EDT.TO · FCF · TTM · margin & CAGR

Free cash flow was −$9.7M for FY2025 (fiscal year ending 2025-12-31), down 9.9% year-over-year The FCF margin was -398.0%.

FY2025 Free Cash Flow−$9.7M▼ -9.9% YoY

Trailing 12M (TTM)−$11.1Mtrailing 4 quarters sum

FCF Margin-398.0%−$9.7M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

EDT.TO · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$11.6M(0M)−$9.7M▼ 9.9%-398.0%

FY2024−$8.8M(0M)−$8.8M▲ +18.9%-386.9%

FY2023−$10.7M(0M)−$10.9M▼ 9.8%-682.5%

FY2022−$9.9M(0M)−$9.9M▼ 8.2%-595.9%

FY2021−$8.7M(0M)−$9.2M▼ 1337.2%-460.1%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

EDT.TO · P/FCF · FCF yield · FCF per share

Spectral Medical Inc. (EDT.TO) reported negative free cash flow of −$0.01B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

EDT.TO · cash flow statement · operating / investing / financing

For FY2025, Spectral Medical Inc. generated −$11.6M in operating cash flow and spent 0M in capital expenditures, yielding −$9.7M in free cash flow.

Operating Activities

−$11.6M

Cash from core business operations

2025-12-31

Investing Activities

−$0.2M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$12.9M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$11.6M) − |CapEx| (0M) = FCF (−$9.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

EDT.TO vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Spectral Medical Inc.YOU

EDT.TO

−$9.7M-9.9%-398.0%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Spectral Medical Inc. (EDT.TO) reported free cash flow of −$9.7M for FY2025 (fiscal year ending 2025-12-31), down 9.9% year-over-year. The FCF margin was -398.0%.

Spectral Medical Inc. has reported negative free cash flow in recent periods, indicating capital expenditures have exceeded operating cash flow. Data available for 15 fiscal years.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

EDT.TO free cash flow · 8 questions

Spectral Medical Inc. free cash flow was −$9.7M for FY2025, down 9.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$11.1M.

EDT.TO free cash flowEDT.TO FCFEDT.TO FCF 2025EDT.TO free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Spectral Medical Inc. · Spectral Medical Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026